The role of triglycerides in cardiovascular risk
Authors:
- 1 November 2008
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 10 (6) , 505-511
Abstract
Triglycerides’ role in coronary heart disease (CHD) risk assessment has long been debated. Although meta-analyses have suggested that triglycerides are an independent risk factor for CHD, a consensus has emerged that triglycerides more appropriately represent a biomarker of CHD risk rather than an independent risk factor. Ongoing studies will determine whether triglyceride lowering confers additional CHD benefit beyond that attained via low-density lipoprotein (LDL) cholesterol reduction. The American Diabetes Association presently recommends lowering elevated triglycerides as a secondary therapeutic target after LDL cholesterol, whereas other organizations, such as the National Cholesterol Education Program, recommend non-high-density lipoprotein cholesterol as the second priority after attaining the LDL cholesterol goal. However, reducing very high triglycerides (ie, > 500 mg/dL) remains a sufficiently high priority in affected individuals.Keywords
This publication has 53 references indexed in Scilit:
- Relative Atherogenicity and Predictive Value of Non–High-Density Lipoprotein Cholesterol for Coronary Heart DiseaseThe American Journal of Cardiology, 2008
- HypertriglyceridemiaNew England Journal of Medicine, 2007
- Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in WomenJAMA, 2007
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Evolution of the Lipid Trial Protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) TrialThe American Journal of Cardiology, 2007
- Are Remnant-Like Particles Independent Predictors of Coronary Heart Disease Incidence?Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in the Asia-Pacific RegionCirculation, 2004
- Consensus Statement: Role of Therapy With “Statins” in Patients With HypertriglyceridemiaThe American Journal of Cardiology, 1998
- Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged menThe American Journal of Cardiology, 1996
- Low-density lipoproteins of the postprandial state induce cellular cholesteryl ester accumulation in macrophages.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994